A study on the efficacy and safety of Blonanserin in Indian patients in Ahmedabad: a randomized, active controlled, phase III clinical trial
Journal Title: INDIAN JOURNAL OF MENTAL HEALTH - Year 2017, Vol 4, Issue 4
Abstract
Introduction: Blonanserin is a novel atypical antipsychotic with higher dopamine D 2 receptor occupancy and lower serotonin 5-HT2A receptor blocking activity as compared to the other atypical antipsychotics.The objective of this study was to compare the efficacy and safety of blonanserin with haloperidol in Indian patients with schizophrenia. Methodology: This was an 8 week, randomized, open label, active controlled, multicentre study. Patients diagnosed with schizophrenia according to the DSM-IV criteria were enrolled in the study. Patients were randomized to receive either blonanserin (16 mg/day) or haloperidol (4.5 mg/day). Patients were assessed on an out-patient basis after every 2 weeks for clinical efficacy [Positive and Negative Syndrome Scale (PANSS) total and factor scores], Clinical Global Impressions–severity CGI-S, Clinical Global Impressions–Improvement (CGI-I), Global Assessment of Efficacy (CGI-C), adverse events and drug compliance. Results: At our centre, total 60 patients were randomized it the study with 30 patients each in Blonanserin and Haloperidol group. Both blonanserin and haloperidol were effective in reducing the PANSS score at the end of the study as compared to the baseline (P<0.001). There was a significantly more decline in the mean total PANSS score from 78.5 ± 15.6 (range: 43-105) at baseline (Week 0) to 35.0 ± 8.8 (range: 14-54) at last assessment (Week 8) in the patients enrolled in Study Arm of Blonanserin; as compared to decline in the same from 67.7 ± 14.0 (range: 39-93) at baseline (Week 0) to 31.0 ± 5.7 (range: 21-43) at last assessment (Week 8) in Study Arm of Haloperidol. Blonanserin was superior to Haloperidol in control of negative symptoms of schizophrenia. On Clinical Global Impression for change in disease severity (CGIS) at the end of treatment period;10 (35.7%) patients had “much improvement” in Blonanser in group.On the otherhand, 5 (17.2%) patients had “much improvement” in Haloperidol group. Blonanserin was welltolerated by the patients with the most common adverse event being extrapyramidal symptoms.Conclusion: Blonanserin was found to be non-inferior to haloperidol in the treatment of patients with schizophrenia and was superior to haloperidol for the treatment of negative symptoms of schizophrenia. Blonanserin has a great potential to be a new atypical first line drug for the treatment of schizophrenia.
Authors and Affiliations
Bhavesh Lakdawala, Mahemubin S. Lahori, Ganpat K. Vankar
Keywords
Related Articles
- EP ID EP274941
- DOI 10.30877/IJMH.4.4.2017.359-366
- Views 94
- Downloads 0
A Survey of Psychiatrist’s perception regarding the concept of ‘Mind’ and its position in psychiatry today
The term ‘mind’ is important in Psychiatry. For example, when certifying Testamentary Capacity, Psychiatrists certify that a person has a sound ‘mind’. ‘Mental’ means ‘related to mind’. With advances in neurobiology, Men...
Psychodynamic theories of Schizophrenia – revisited
There are various theories that have been posited with respect to the development of schizophrenia, Much before the neurobiological and social hypotheses explaining schizophrenia, various psychoanalysts and psychodynamic...
The Impact of Anxiety on Self - Concept and Adjustment of Adolescents with Learning Disabilities in Mumbai
The purpose of the current study was to investigate the relationship between anxiety, self - concept and adjustment among adolescent with learning disabilities (LD) in Mumbai. The study consisted of 59 male and 51 female...
EEG referral pattern in a tertiary care teaching hospital : a retrospective study
Background : EEG is widely available and is an important tool in the diagnosis of many neuropsychiatric disorders. Considering its low sensitivity, appropriate referral for EEG is vital. Methodology : All the EEG reques...
An Epidemiological Survey of Childhood Developmental Disorders in primary school children
Developmental disorders are common in childhood and are seen in primary school children. Early detection shall lead to early intervention and better outcomes at a later age. The following study was aimed to assess the pr...